Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Nature Biomedical Engineering |
Vol/bind | 2 |
Sider (fra-til) | 279-292 |
DOI | |
Status | Udgivet - 2018 |
Bibliografisk note
Authoe correction: https://www.nature.com/articles/s41551-018-0281-3
Links
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447057/pdf/nihms-951102.pdf
Accepteret manuskript
ID: 216468062